Reproductive endocrinology

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial

JAMA Netw OpenPublished Secondary analysis of the TRAVERSE randomised trial

An erratum to this article was published (JAMA Netw Open, 2 Jan 2024 ↗)

Authors' conclusion

In middle-aged and older men with hypogonadism and anemia, TRT was more efficacious than placebo in correcting anemia. Among men who were not anemic, a smaller proportion of testosterone-treated men developed anemia than placebo-treated men.

Study context

Population
Men aged 45 to 80 years with hypogonadism (2 testosterone <300 ng/dL, hypogonadal symptoms) and cardiovascular disease (CVD) or increased CVD risk, 316 US sites; 815 with anemia, 4379 without815 with anemia
Participants
5,204 men
Comparison
1.62% testosterone gel vs placebo gel daily
Primary endpoint
Proportion of participants with anemia (hemoglobin <12.7 g/dL) whose anemia remitted (hemoglobin ≥12.7 g/dL)
Follow-up
Over the study duration
Methodological detailsplacebo-controlled, multicentre, stratified for preexisting CVD, Enrolled May 2018 to February 2022; last visit January 2023
  • Placebo-controlled
  • Multicentre
  • Stratified for preexisting CVD
  • Enrolled May 2018 to February 2022; last visit January 2023

Primary result

As reported in the abstract

Anemia corrected · 6, 12, 24, 36 and 48 months
6 months: Testosterone vs Placebo
143 of 349 [41.0%] vs 103 of 375 [27.5%]
12 months: Testosterone vs Placebo
152 of 338 [45.0%] vs 122 of 360 [33.9%]
24 months: Testosterone vs Placebo
124 of 290 [42.8%] vs 95 of 307 [30.9%]
36 months: Testosterone vs Placebo
94 of 216 [43.5%] vs 76 of 229 [33.2%]
48 months: Testosterone vs Placebo
41 of 92 [44.6%] vs 38 of 97 [39.2%]

Secondary outcomes

Incidence of anemia among men without anemia

Significantly smaller proportion of testosterone-treated men developed anemia than placebo-treated men

Hemoglobin and energy level

Changes in hemoglobin were associated with changes in energy level

Original publication

Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. Published 2 October 2023. doi:10.1001/jamanetworkopen.2023.40030

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.